MGRX

Mangoceuticals, Inc. (MGRX) ESG Analysis Analysis (2026)

Invetso Score: 5.3/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.2 (Moderate)

R&D intensity is effectively absent versus peers, which limits evidence of resource-efficient innovation but also reduces direct environmental disclosure relevance in this profile.

Low leverage and negligible net debt reduce balance-sheet pressure that can otherwise constrain environmental compliance spending, though peers often show similar capital structure.

No disclosed carbon, energy, water, or waste metrics were provided, leaving environmental comparability weaker than peers with more complete sustainability reporting.

Gross margin strength can support funding for environmental controls, but it is not itself an environmental advantage versus peers without direct emissions data.

Social

Score:

Stock-based compensation is high versus typical peers, which can support retention and alignment but may also signal heavier dilution-related employee concerns.

No workforce, safety, turnover, or community metrics were provided, so social positioning cannot be shown as stronger than peers with fuller disclosure.

The absence of disclosed human-capital indicators weakens transparency relative to peers that report training, diversity, and injury-rate data in filings.

Capital discipline appears mixed because low debt reduces stress on stakeholders, yet the compensation structure remains a notable peer-relative social governance concern.

Governance

Score:

Debt-to-equity is very low and net debt is slightly negative, which reduces creditor-risk governance pressure but does not distinguish the company from conservative peers.

Stock-based compensation at 6.9% of revenue is materially elevated, suggesting weaker shareholder-alignment discipline than peers with lower dilution.

R&D spend is reported as zero, which may indicate limited long-term investment transparency relative to peers that disclose more detailed capital-allocation priorities.

The provided metrics do not include board, audit, or ownership controls, so governance strength cannot be established above peers with fuller filing disclosure.

Overall Score

Score:

MGRX shows moderate ESG positioning overall because limited disclosure and elevated stock-based compensation offset the benefits of low leverage and capital discipline.

Score Driver: Elevated Stock-Based Compensation Relative To Peers

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Mangoceuticals, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →